A pilot open-label feasibility trial examining an adjunctive mindfulness intervention for adolescents with obesity

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2055-5784

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: A pilot open-label feasibility trial examining an adjunctive mindfulness intervention for adolescents with obesity ; volume:6 ; number:1 ; day:6 ; month:6 ; year:2020 ; pages:1-11 ; date:12.2020
Pilot and feasibility studies ; 6, Heft 1 (6.6.2020), 1-11, 12.2020

Creator: Cotter, Elizabeth W.
Hornack, Sarah E.
Fotang, Jenny P.
Pettit, Elizabeth
Mirza, Nazrat M.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40814-020-00621-1

URN: urn:nbn:de:101:1-2020080719074605585853

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Cotter, Elizabeth W.
Hornack, Sarah E.
Fotang, Jenny P.
Pettit, Elizabeth
Mirza, Nazrat M.
SpringerLink (Online service)

Other Objects (12)

Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial

Long-term efficacy and safety from an open-label extension of adjunctive cenobamate in patients with uncontrolled focal seizures

Long‐term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: an open‐label, follow‐up trial

Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder

$Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial$

Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial

A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance

Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE)

Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study

Adjunctive use of mindfulness-based mobile application in depression: randomized controlled study

Examining How Headspace Impacts Mindfulness Mechanisms Over an 8-Week App-Based Mindfulness Intervention

Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study

A single-arm, open-label pilot study of neuroimaging, behavioral, and peripheral inflammatory correlates of mindfulness-based stress reduction in multiple sclerosis

Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial

Long-term efficacy and safety from an open-label extension of adjunctive cenobamate in patients with uncontrolled focal seizures

Long‐term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: an open‐label, follow‐up trial

Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder

$Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial$

Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial

A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance

Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE)

Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study

Adjunctive use of mindfulness-based mobile application in depression: randomized controlled study

Examining How Headspace Impacts Mindfulness Mechanisms Over an 8-Week App-Based Mindfulness Intervention

Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study

A single-arm, open-label pilot study of neuroimaging, behavioral, and peripheral inflammatory correlates of mindfulness-based stress reduction in multiple sclerosis

Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial

Long-term efficacy and safety from an open-label extension of adjunctive cenobamate in patients with uncontrolled focal seizures

Long‐term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: an open‐label, follow‐up trial

Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder

$Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial$

Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial

A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance

Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE)

Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study

Adjunctive use of mindfulness-based mobile application in depression: randomized controlled study

Examining How Headspace Impacts Mindfulness Mechanisms Over an 8-Week App-Based Mindfulness Intervention

Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study

A single-arm, open-label pilot study of neuroimaging, behavioral, and peripheral inflammatory correlates of mindfulness-based stress reduction in multiple sclerosis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

A pilot open-label feasibility trial examining an adjunctive mindfulness intervention for adolescents with obesity

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial

Long-term efficacy and safety from an open-label extension of adjunctive cenobamate in patients with uncontrolled focal seizures

Long‐term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: an open‐label, follow‐up trial

Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder

Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial

A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance

Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE)

Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study

Adjunctive use of mindfulness-based mobile application in depression: randomized controlled study

Examining How Headspace Impacts Mindfulness Mechanisms Over an 8-Week App-Based Mindfulness Intervention

Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study

A single-arm, open-label pilot study of neuroimaging, behavioral, and peripheral inflammatory correlates of mindfulness-based stress reduction in multiple sclerosis

Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial

Long-term efficacy and safety from an open-label extension of adjunctive cenobamate in patients with uncontrolled focal seizures

Long‐term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: an open‐label, follow‐up trial

Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder

Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial

A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance

Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE)

Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study

Adjunctive use of mindfulness-based mobile application in depression: randomized controlled study

Examining How Headspace Impacts Mindfulness Mechanisms Over an 8-Week App-Based Mindfulness Intervention

Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study

A single-arm, open-label pilot study of neuroimaging, behavioral, and peripheral inflammatory correlates of mindfulness-based stress reduction in multiple sclerosis

Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients < 16 Years with Epilepsy: An Open-Label Trial

Long-term efficacy and safety from an open-label extension of adjunctive cenobamate in patients with uncontrolled focal seizures

Long‐term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: an open‐label, follow‐up trial

Results from a long-term open-label extension study of adjunctive buprenorphine/samidorphan combination in patients with major depressive disorder

Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial

A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance

Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE)

Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study

Adjunctive use of mindfulness-based mobile application in depression: randomized controlled study

Examining How Headspace Impacts Mindfulness Mechanisms Over an 8-Week App-Based Mindfulness Intervention

Perampanel as monotherapy or first adjunctive therapy in pediatric and adult patients with epilepsy: the first United States-based phase IV open-label ELEVATE study

A single-arm, open-label pilot study of neuroimaging, behavioral, and peripheral inflammatory correlates of mindfulness-based stress reduction in multiple sclerosis

Related objects

Reset password